Molina Healthcare Inc would buy Magellan Complete Care, Magellan Health Inc’s MGLN.N unit that provides managed-care health plans, for about $820 million, the healthcare insurer said on Thursday. Magellan shares...
Novartis buys Amblyotech to develop tech products for lazy eye
Novartis has bought U.S. software start-up Amblyotech, to develop digital technology to treat children and adults with lazy eye, the Swiss drugmaker said on Monday. Novartis said it would work with Ubisoft and McGill...
Danaher wins U.S. approval to buy GE Biopharma, with conditions
Danaher Corp has won U.S. antitrust approval to buy General Electric’s biopharmaceutical business, GE Biopharma, for $21.4 billion on condition it sell some assets, the Federal Trade Commission said on Thursday. South...
Australia’s Healius rejects Partners Group’s $1.3 billion buyout offer
Australia’s Healius Ltd on Monday turned down a A$2.12 billion ($1.31 billion) takeover offer from private equity firm Partners Group, saying it undervalued the medical center operator. Healius, however, said it was...
Cadila board okays transfer of animal healthcare business to subsidiary
Drug firm Cadila Healthcare on Wednesday said its board has approved the transfer of its animal healthcare business to its wholly-owned arm Zydus Animal Health and Investments Ltd (ZAHL) as part of its internal...
Invitae Acquires Diploid, Maker Of AI Engine To Enable Clinical Diagnosis Using Whole Genome Sequencing In Minutes
* INVITAE ACQUIRES DIPLOID, MAKER OF ARTIFICIAL-INTELLIGENCE ENGINE TO ENABLE CLINICAL DIAGNOSIS USING WHOLE GENOME SEQUENCING IN MINUTES * INVITAE CORP – WILL ACQUIRE DIPLOID FOR APPROXIMATELY $95 MILLION *...
Singapore-based Quadria Capital raises $595 million fund for healthcare-focused deals
Singapore-based private equity firm Quadria Capital has closed its second fund at its maximum of $595 million, it said on Wednesday. The firm, which focuses on healthcare investments around South and Southeast Asia...
NMC’s Shetty looks to sell pharma business
NMC Health Plc founder Bavaguthu Raghuram Shetty is considering selling his Abu Dhabi-based pharmaceuticals business, Neopharma, after drawing interest from potential investors, according to people with knowledge of the...
Thermo Fisher agrees to buy genetic tester Qiagen in $11.5 billion deal
Thermo Fisher Scientific Inc said on Tuesday it agreed to acquire German genetic testing company Qiagen NV in an $11.5 billion deal as the U.S.-based company looks to bolster its health diagnostic business. Qiagen...
Piramal Enterprises receives $900 million on closing sale of DRG business
Piramal Enterprises on Monday said it has received $900 million (around Rs 6,500 crore) on completion of divestment of stake in its healthcare insights and analytics business to US-headquartered Clarivate Analytics. The...
Gilead buys Forty Seven for $4.9 billion to bolster cancer drug pipeline
Gilead Sciences Inc said on Monday it would buy Forty Seven Inc for $4.9 billion in cash, adding an experimental treatment that targets blood cancer to its portfolio of oncology drugs. Shares of Forty Seven jumped 62%...
Abu Dhabi wealth fund weighs stake in BR Shetty’s troubled NMC
Abu Dhabi wealth fund Mubadala Investment Co. is considering a potential investment in NMC Health Plc — a sign the emirate is keen to address the worsening crisis at the troubled hospital operator, people familiar...
